XTL Biopharmaceuticals Ltd. (XTLB)
1.98
-0.01
(-0.50%)
USD |
NASDAQ |
Oct 09, 16:00
1.98
0.00 (0.00%)
After-Hours: 20:00
XTL Biopharmaceuticals Market Cap : 4.684M for Oct. 9, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 09, 2026 | 4.684M |
| October 08, 2026 | 4.708M |
| October 07, 2026 | 4.684M |
| October 06, 2026 | 4.778M |
| October 05, 2026 | 5.157M |
| October 02, 2026 | 5.110M |
| October 01, 2026 | 5.039M |
| September 30, 2026 | 5.441M |
| September 29, 2026 | 5.228M |
| September 28, 2026 | 5.275M |
| September 25, 2026 | 5.205M |
| September 24, 2026 | 5.701M |
| September 23, 2026 | 5.205M |
| September 22, 2026 | 5.626M |
| September 21, 2026 | 5.626M |
| September 18, 2026 | 5.677M |
| September 17, 2026 | 5.677M |
| September 16, 2026 | 5.654M |
| September 15, 2026 | 5.914M |
| September 14, 2026 | 5.748M |
| September 11, 2026 | 6.054M |
| September 10, 2026 | 5.961M |
| September 09, 2026 | 5.961M |
| September 08, 2026 | 5.985M |
| September 04, 2026 | 5.985M |
| Date | Value |
|---|---|
| September 03, 2026 | 5.914M |
| September 02, 2026 | 6.292M |
| September 01, 2026 | 5.488M |
| August 31, 2026 | 5.890M |
| August 28, 2026 | 5.843M |
| August 27, 2026 | 6.103M |
| August 26, 2026 | 6.103M |
| August 25, 2026 | 6.151M |
| August 24, 2026 | 6.210M |
| August 21, 2026 | 6.576M |
| August 20, 2026 | 6.534M |
| August 19, 2026 | 7.050M |
| August 18, 2026 | 7.641M |
| August 17, 2026 | 6.151M |
| August 14, 2026 | 6.588M |
| August 13, 2026 | 6.624M |
| August 12, 2026 | 6.364M |
| August 11, 2026 | 6.269M |
| August 10, 2026 | 6.789M |
| August 07, 2026 | 6.955M |
| August 06, 2026 | 6.789M |
| August 05, 2026 | 6.742M |
| August 04, 2026 | 6.813M |
| August 03, 2026 | 6.768M |
| July 31, 2026 | 6.671M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| BioLineRx Ltd. | 9.680M |
| Kamada Ltd. | 466.17M |
| Can-Fite BioPharma Ltd. | 4.071M |
| Eocene Ltd. | 3.545M |
| Revium Recovery, Inc. | 86.84M |
Market Cap Related Metrics
| Price | 1.98 |